Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients
出版年份 2022 全文链接
标题
Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients
作者
关键词
-
出版物
BIOCHEMICAL GENETICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-02-19
DOI
10.1007/s10528-022-10199-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The association of single nucleotide polymorphisms (SNPs) with breast density and breast cancer survival: the Malmö Diet and Cancer Study
- (2020) Hanna Sartor et al. ACTA RADIOLOGICA
- 70P Genetic polymorphisms of ESR1 are associated with hormone resistance to aromatase inhibitors therapy in patients with metastatic luminal breast cancer (MLBC)
- (2020) T. Tarasenko et al. ANNALS OF ONCOLOGY
- ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy
- (2019) Jia Zhong et al. Thoracic Cancer
- Pathways to Endocrine Therapy Resistance in Breast Cancer
- (2019) Md. Moquitul Haque et al. Frontiers in Endocrinology
- The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer
- (2019) Pedro De Marchi et al. ORAL ONCOLOGY
- SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
- (2018) Raffaele Palmirotta et al. Oncotarget
- ESR1 PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies
- (2018) Xiaoqi Liu et al. Journal of Cancer
- Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies
- (2017) Yining Zhao et al. OncoTargets and Therapy
- PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women
- (2016) Hong-Tao Ren et al. MEDICINE
- Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population
- (2016) Zhi-Jun Dai et al. MEDICINE
- A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer
- (2016) Taishun Li et al. PLoS One
- Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
- (2016) Shabbir Ahmed et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Progress in adjuvant chemotherapy for breast cancer: an overview
- (2015) Jesus Anampa et al. BMC Medicine
- Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis
- (2015) Yiming Zhang et al. MEDICAL SCIENCE MONITOR
- Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer
- (2015) Yosuke Hirotsu et al. Molecular Genetics & Genomic Medicine
- Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies
- (2014) Zhenwei Gu et al. TUMOR BIOLOGY
- Genetic polymorphims of estrogen receptor alpha −397 PvuII (T>C) and −351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility
- (2013) A. C. Ramalhinho et al. MOLECULAR BIOLOGY REPORTS
- Genomics, personalized medicine and cancer practice
- (2012) Janet Dancey CLINICAL BIOCHEMISTRY
- Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
- (2012) John R Mackey et al. LANCET ONCOLOGY
- Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women
- (2010) Lori C. Sakoda et al. Cancer Epidemiology
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- A review of estrogen receptor α gene (ESR1) polymorphisms, mood, and cognition
- (2010) Erin E. Sundermann et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Genome-wide association study identifies five new breast cancer susceptibility loci
- (2010) Clare Turnbull et al. NATURE GENETICS
- Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis
- (2009) Ni Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
- (2009) Stephen Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
- (2009) Margot Burnell et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
- (2009) Paul Ellis et al. LANCET
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North American Breast Cancer Intergroup Trial E 2197
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started